ArticleJournal of medical cases2026

High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax.

Caryn Louise D Gutierrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.